ASML remains the sole commercial producer of EUV lithography machines, underscoring its pivotal role in the tech competition between the United States and China.

ASML’s stock dipped in early trading on the news, though the company has posted substantial gains for the year so far.

Analysts note a strategic and legal standoff with no public evidence yet, inviting questions about timing, motives, and broader implications for Western semiconductor supply chains.

Background is provided on the CEO’s historical view of China’s position in chipmaking, adding context to the current tensions.

The case places ASML at heightened geopolitical and regulatory risk as the leading EUV supplier, with potential implications for its revenue mix and global operations.

ASML denies shipping EUV lithography machines or any EUV components to China amid U.S. export-control concerns, while continuing to stress that its most advanced EUV systems are large, require on-site support, and are not easily deployed abroad.

China has been a major revenue source for ASML, highlighting the geopolitical stakes as the company sits at the center of supplying chips used in AI.

Coverage frames ASML at the center of a broader geopolitical race over semiconductor tech, with a balance of regulatory enforcement and industry competitiveness shaping supply chains.

ASML notes prior financial impacts from restrictions and reports that China’s share of sales declined in early 2026, while affirming compliance with international licenses and regulations.

Management has signaled a normalization of China business due to restrictions on advanced units, predicting a continued decline in China’s share of sales.

The situation remains publicly unresolved, with officials declining to share specific records or actions, while the policy debate among U.S., European, and allied partners continues.

Investors are watching for possible increases in compliance costs, tighter export controls, and effects on ASML’s ability to serve China, which could impact orders and margins.